Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah
2022年9月21日 - 7:00PM
JCN Newswire
Leading genomics and biopharmaceutical specialist Malaysian
Genomics Resource Centre Berhad (Bursa: MGRC, 0155) is pleased to
report that the Group has signed a letter of intent (LOI) with the
Faculty of Science and Natural Resources, Universiti Malaysia Sabah
(UMS) and Rinani Genotec Sdn Bhd (Genotec) to collaborate on
research and development (R&D) in genetics, and regenerative
and alternative medicines.
Under the LOI, MGRC, which owns a high-throughput sequencing lab,
advanced microarray facility, and new state-of-the-art cell
processing lab, as well as Genotec, which specializes in biomedical
treatments using stem cells, will assist in strengthening the
teaching and research activities of the undergraduate programme at
UMS' Faculty of Science and Natural Resources.
This cooperation will enable the exchange of research resources and
ideas to enhance the quality of research at UMS, as well as create
opportunities for students from the Faculty of Science and Natural
Resources to serve their internship period at MGRC or Genotec.
Chairman of Malaysian Genomics, Datuk Seri Dr. Chen Chaw Min, said,
"We are happy to assist UMS undergraduates in pursuing their
R&D goals so that they have a better understanding of their
field of study. This is also in support of the National
Biotechnology Policy 2.0 launched recently focusing on agriculture
and food security, healthcare and wellbeing, as well as industrial
and the circular economy."
The Dean of the Faculty of Science and Natural Resources, UMS,
Professor Dr. Jualang Azlan Gansau said, "UMS is actively engaging
in research as well as teaching activities and the involvement of
industry is crucial in ensuring the relevance of such activities
conducted at the University."
The signing of the LOI followed UMS' visit to MGRC's Biosafety
Level 2 cGMP (Current Good Manufacturing Practice)-certified
laboratory, which is used for the production of cell therapies,
including CAR T-cell therapies for various cancers.
Malaysian Genomics Resource Centre Berhad: 0155 [BURSA: MGRC] [RIC:
MGRC:KL] [BBG: MGRC:MK], http://www.mgrc.com.my/
Copyright 2022 JCN Newswire . All rights reserved.